[DOI] [PMC free article] [PubMed] [Google Scholar] 151.Lei Y., Martinez C.G., Torres-Odio S., Bell S.L., Birdwell C.E., Bryant J.D., Tong C.W., Watson R.O., West L.C., West A.P
Your GLP1R and GIPR variants influence receptor sensitivity
After numerous clinical trials by administration of the endogenous hormone to the body, the scientists found that though it appeared to work, -MSH had a very short half-life in the body to be practical as a therapeutic drug
Twelve months after stopping a GLP-1, 33% of patients had further improved their HbA1c compared to when they discontinued the GLP-1, 46% kept some of their improvement, and 21% had a worse HbA1c compared to their pre-GLP-1 level
May Prevent the Need for Surgery Surgery is typically for whenever youve exhausted all your options
-